Literature DB >> 34373192

Molecular Determinants of SARS-CoV-2 Variants.

Arinjay Banerjee1, Karen Mossman2, Nathalie Grandvaux3.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolution is expected, given the nature of virus replication. Selection and establishment of variants in the human population depend on viral fitness and on molecular and immunological selection pressures. Here we discuss how mechanisms of replication and recombination may contribute to the emergence of current and future variants of SARS-CoV-2.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; recombination; replication; variants

Year:  2021        PMID： 34373192     DOI： 10.1016/j.tim.2021.07.002

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


  10 in total

Review 1.  Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.

Authors:  Cong Sun; Chu Xie; Guo-Long Bu; Lan-Yi Zhong; Mu-Sheng Zeng
Journal:  Signal Transduct Target Ther       Date:  2022-06-28

2.  Insertion-and-Deletion Mutations between the Genomes of SARS-CoV, SARS-CoV-2, and Bat Coronavirus RaTG13.

Authors:  Tetsuya Akaishi
Journal:  Microbiol Spectr       Date:  2022-06-06

3.  Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.

Authors:  Gerald Wirnsberger; Vanessa Monteil; Brett Eaton; Elena Postnikova; Michael Murphy; Benedict Braunsfeld; Ian Crozier; Franz Kricek; Janine Niederhöfer; Alice Schwarzböck; Helene Breid; Anna Sanchez Jimenez; Agnes Bugajska-Schretter; Alexander Dohnal; Christine Ruf; Romana Gugenberger; Astrid Hagelkruys; Nuria Montserrat; Michael R Holbrook; Chris Oostenbrink; Robert H Shoemaker; Ali Mirazimi; Josef M Penninger
Journal:  bioRxiv       Date:  2021-09-10

4.  A Paradigm Shift in the Combination Changes of SARS-CoV-2 Variants and Increased Spread of Delta Variant (B.1.617.2) across the World.

Authors:  Chiranjib Chakraborty; Ashish Ranjan Sharma; Manojit Bhattacharya; Govindasamy Agoramoorthy; Sang-Soo Lee
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

5.  Metagenomic pipeline for identifying co-infections among distinct SARS-CoV-2 variants of concern: study cases from Alpha to Omicron.

Authors:  Jose Arturo Molina-Mora; Estela Cordero-Laurent; Melany Calderón-Osorno; Edgar Chacón-Ramírez; Francisco Duarte-Martínez
Journal:  Sci Rep       Date:  2022-06-07       Impact factor: 4.996

6.  Rescuing Low Frequency Variants within Intra-Host Viral Populations directly from Oxford Nanopore sequencing data.

Authors:  Yunxi Liu; Joshua Kearney; Medhat Mahmoud; Bryce Kille; Fritz J Sedlazeck; Todd J Treangen
Journal:  bioRxiv       Date:  2021-09-06

Review 7.  Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications.

Authors:  Aakriti Dubey; Shweta Choudhary; Pravindra Kumar; Shailly Tomar
Journal:  Curr Microbiol       Date:  2021-12-14       Impact factor: 2.188

8.  Rescuing low frequency variants within intra-host viral populations directly from Oxford Nanopore sequencing data.

Authors:  Yunxi Liu; Joshua Kearney; Medhat Mahmoud; Bryce Kille; Fritz J Sedlazeck; Todd J Treangen
Journal:  Nat Commun       Date:  2022-03-14       Impact factor: 14.919

9.  Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.

Authors:  Vanessa Monteil; Brett Eaton; Elena Postnikova; Michael Murphy; Benedict Braunsfeld; Ian Crozier; Franz Kricek; Janine Niederhöfer; Alice Schwarzböck; Helene Breid; Stephanie Devignot; Jonas Klingström; Charlotte Thålin; Max J Kellner; Wanda Christ; Sebastian Havervall; Stefan Mereiter; Sylvia Knapp; Anna Sanchez Jimenez; Agnes Bugajska-Schretter; Alexander Dohnal; Christine Ruf; Romana Gugenberger; Astrid Hagelkruys; Nuria Montserrat; Ivona Kozieradzki; Omar Hasan Ali; Johannes Stadlmann; Michael R Holbrook; Connie Schmaljohn; Chris Oostenbrink; Robert H Shoemaker; Ali Mirazimi; Gerald Wirnsberger; Josef M Penninger
Journal:  EMBO Mol Med       Date:  2022-07-04       Impact factor: 14.260

10.  A comparison of high-throughput SARS-CoV-2 sequencing methods from nasopharyngeal samples.

Authors:  Zuzana Gerber; Christian Daviaud; Damien Delafoy; Florian Sandron; Enagnon Kazali Alidjinou; Jonathan Mercier; Sylvain Gerber; Vincent Meyer; Anne Boland; Laurence Bocket; Robert Olaso; Jean-François Deleuze
Journal:  Sci Rep       Date:  2022-07-22       Impact factor: 4.996
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.